Alyeska Investment Group
NAMSW icon

Alyeska Investment Group’s NewAmsterdam Pharma Warrant NAMSW Stock Holding History

Alyeska Investment Group’s Portfolio NAMSW Stock Details NAMSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-285,105
Closed -$1.89M – 515
2022
Q4 		$1.89M Buy
+285,105
New +$235K 0.02% 323

Other funds holding NAMSW

HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ETH
Exos TFP Holdings New York $162M AUM 16.08% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Alyeska Investment Group's NAMSW Position: Q1 2023 in Review

Alyeska Investment Group sold out of NewAmsterdam Pharma Warrant (NAMSW) in Q1 2023, closing a stake of 285,105 shares — an estimated $1.89M sold.

Alyeska Investment Group first reported a position in NAMSW in Q4 2022 and held it in 1 quarter. The position peaked at $1.89M in Q4 2022. 18 funds tracked by Wall St. Rank hold NAMSW as of Q1 2023.

  • Alyeska Investment Group reported no remaining NewAmsterdam Pharma Warrant position as of Q1 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 285,105 NewAmsterdam Pharma Warrant shares in Q1 2023, an estimated $1.89M.
  • Alyeska Investment Group first reported a position in NewAmsterdam Pharma Warrant in Q4 2022 and held it in 1 quarter.
  • Alyeska Investment Group's NewAmsterdam Pharma Warrant position peaked at $1.89M in Q4 2022.
  • 18 funds tracked by Wall St. Rank held NewAmsterdam Pharma Warrant as of Q1 2023.

Based on Alyeska Investment Group's 13F filing for Q1 2023, filed 15 May 2023.